Literature DB >> 18958364

Neurofibromatosis: the role of guanosine triphosphatase activating proteins in sensory neuron function.

Cynthia M Hingtgen1.   

Abstract

Neurofibromatosis type 1 (NF1) is a common autosomal dominant disease characterized by formation of multiple benign and malignant tumors. People with this disorder also experience chronic pain, which can be disabling. Neurofibromin, the protein product of the Nf1 gene, is a guanosine triphosphatase activating protein (GAP) for p21Ras (Ras). Loss of Nf1 results in an increase in activity of the Ras transduction cascade. Because of the growing evidence suggesting involvement of downstream components of the Ras transduction cascade in the sensitization of nociceptive sensory neurons, we examined the stimulus-evoked release of the neuropeptides, substance P (SP) and calcitonin gene-related peptide (CGRP), from primary sensory neurons of mice with a mutation of the Nf1 gene (Nf1+/-). Measuring the levels of SP and CGRP by radioimmunoassay, we demonstrated that capsaicin-stimulated release of neuropeptides is 3-5 folds higher in spinal cord slices from Nf1+/- mice than that from wildtype mouse tissue. In addition, the potassium- and capsaicin-stimulated release of CGRP from the culture of sensory neurons isolated from Nf1+/- mice was more than double that from the culture of wildtype neurons. Using patch-clamp electrophysiological techniques, we also examined the excitability of capsaicin-sensitive sensory neurons. It was found that the number of action potentials generated by the neurons from Nf1+/- mice, responding to a ramp of depolarizing current, was more than three times of that generated by wildtype neurons. Consistent with that observation, neurons from Nf1+/- mice had lower firing thresholds, lower rheobase currents and shorter firing latencies compared with wildtype neurons. These data clearly demonstrate that GAPs, such as neurofibromin, can alter the excitability of nociceptive sensory neurons. The augmented response of sensory neurons with altered Ras signaling may explain the abnormal pain sensations experienced by people with NF1 and suggests an important role of GAPs in the mechanism of sensory neuron sensitization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958364

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  5 in total

1.  Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1.

Authors:  Douglas R Stewart; Jennifer L Sloan; Lawrence Yao; Andrew J Mannes; Armin Moshyedi; Chyi-Chia Richard Lee; Raf Sciot; Luc De Smet; Victor-Felix Mautner; Eric Legius
Journal:  J Med Genet       Date:  2010-06-07       Impact factor: 6.318

2.  Neurofibromatosis type 1 alternative splicing is a key regulator of Ras signaling in neurons.

Authors:  Melissa N Hinman; Alok Sharma; Guangbin Luo; Hua Lou
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

Review 3.  Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.

Authors:  Shreya S Bellampalli; Rajesh Khanna
Journal:  Pain       Date:  2019-05       Impact factor: 6.961

4.  Systems pharmacology of the nerve growth factor pathway: use of a systems biology model for the identification of key drug targets using sensitivity analysis and the integration of physiology and pharmacology.

Authors:  Neil Benson; Tomomi Matsuura; Sergey Smirnov; Oleg Demin; Hannah M Jones; Pinky Dua; Piet H van der Graaf
Journal:  Interface Focus       Date:  2013-04-06       Impact factor: 3.906

5.  Glomus tumor of the thenar eminence in neurofibromatosis type 1: case report and literature review.

Authors:  Gabriele Scaravilli; Roberto Rossi; Stefano Artiaco; Giovanni Merolla
Journal:  Transl Med UniSa       Date:  2014-12-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.